KemOne ranked among the top searched stocks on 7 days within the past month.


As of 2:30 PM on the 16th, KemOne is trading at 4,875 KRW, down 1.91% from the previous day. This represents a 59.84% increase compared to October 23. KemOne is known as the first non-clinical CRO company in Korea.

Over the past 5 days, individual investors have net purchased 169,907 shares, while foreigners and institutions have net purchased 104,894 shares and net sold 223,908 shares, respectively.



※Source: AI Investment Assistant AI Lassi


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing